EcoR1 Capital LLC 13D and 13G filings for Mirati Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-12-27 4:05 pm Purchase |
2023-12-18 | 13G | Mirati Therapeutics, Inc. MRTX |
EcoR1 Capital LLC | 7,396,979 10.500% |
1,648,580 (+28.68%) |
Filing |
| 2023-10-02 4:08 pm Purchase |
2023-09-22 | 13G | Mirati Therapeutics, Inc. MRTX |
EcoR1 Capital LLC | 5,748,399 8.500% |
5,748,399 (New Position) |
Filing |